SO
KALV

STRS Ohio’s KalVista Pharmaceuticals KALV Stock Holding History

STRS Ohio’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,600
Closed -$42K – 2023
2024
Q1 		$42K Buy
+3,600
New +$48K ﹤0.01% 1779
2023
Q4 		– Sell
-10,800
Closed -$104K – 1966
2023
Q3 		$104K Buy
+10,800
New +$110K ﹤0.01% 1705
2021
Q3 		– Sell
-13,000
Closed -$311K – 2281
2021
Q2 		$311K Sell
13,000
-3,400
-21% -$89K ﹤0.01% 1705
2021
Q1 		$421K Buy
+16,400
New +$431K ﹤0.01% 1629
2019
Q3 		– Sell
-3,100
Closed -$68K – 2109
2019
Q2 		$68K Buy
+3,100
New +$72.7K ﹤0.01% 1884
2015
Q3 		– Sell
-279
Closed -$23.8K – 1915
2015
Q2 		$27K Buy
+279
New +$27.7K ﹤0.01% 1805

Other funds holding KALV

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

STRS Ohio's KALV Position: Q2 2024 in Review

STRS Ohio sold out of KalVista Pharmaceuticals (KALV) in Q2 2024, closing a stake of 3,600 shares — an estimated $42K sold.

STRS Ohio first reported a position in KALV in Q2 2015 and held it in 6 quarters. The position peaked at $421K in Q1 2021. 119 funds tracked by Wall St. Rank hold KALV as of Q2 2024.

  • STRS Ohio reported no remaining KalVista Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • STRS Ohio sold 3,600 KalVista Pharmaceuticals shares in Q2 2024, an estimated $42K.
  • STRS Ohio first reported a position in KalVista Pharmaceuticals in Q2 2015 and held it in 6 quarters.
  • STRS Ohio's KalVista Pharmaceuticals position peaked at $421K in Q1 2021.
  • 119 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2024.

Based on STRS Ohio's 13F filing for Q2 2024, filed 5 Aug 2024.